Portfolio company
Bioherent
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
2 investors
Sectors
About
Bioherent develops in-vitro diagnostic devices using photonic biosensors and nanotechnology for healthcare professionals to detect antibiotic allergies and drug hypersensitivities.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Kenota Health
This company develops point-of-care diagnostic systems that provide rapid allergy testing results for physicians and their patients.
Allergios
This company develops a cell-based diagnostic platform for clinicians to perform precise in vitro allergy tests using blood samples and automated visual analysis.
Abionic
This company develops nanofluidic point-of-care diagnostic platforms and blood tests for healthcare professionals to enable rapid detection of sepsis, allergies and iron deficiencies.
Amulet Allergy
This company develops portable sensors and wearable devices that detect food allergens and contaminants for individual consumers and food manufacturers.
Biomensio
Biomensio develops handheld, multi-analyte biosensing platforms for on-site diagnostic testing in the healthcare, food safety and drug detection sectors.
Allergy Amulet
This company manufactures portable sensors for individuals with food allergies to detect specific ingredients and allergens in meals within one minute.
BIOSERENITY
This company develops wearable medical devices and software for diagnosing and monitoring neurological, sleep and cardiac disorders in patients.
BioPatch
BioPatch develops a non-invasive adhesive patch for breast cancer detection using electrical conductivity measurements for healthcare providers and patients.
